XML 53 R43.htm IDEA: XBRL DOCUMENT v3.24.2.u1
RESTRUCTURING (Details)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 28, 2024
USD ($)
Jun. 30, 2024
USD ($)
facility
Jun. 30, 2023
USD ($)
Jun. 30, 2024
USD ($)
facility
Jun. 30, 2023
USD ($)
Feb. 16, 2024
USD ($)
Feb. 16, 2024
CAD ($)
Dec. 31, 2023
USD ($)
Restructuring                
Number of pharmaceutical manufacturing facilities | facility   3   3        
Restructuring activity expense   $ 0 $ 2,000 $ 0 $ 1,132,000      
Assets held for sale   0   0       $ 8,020,000
Disposal Group, Held-for-Sale, Not Discontinued Operations | Oakville, Ontario Former Manufacturing Facility                
Restructuring                
Consideration $ 13,500,000         $ 14,200,000 $ 19.2  
Payment of commissions, taxes and other related costs 700,000              
Gain on sale of property $ 5,300,000              
Oakville, Ontario, Canada                
Restructuring                
Restructuring activity expense   0 $ 0 0 1,100,000      
Restructuring accrual   $ 0   $ 0        
Assets held for sale               $ 8,000,000.0
Oakville, Ontario, Canada | Employee Severance                
Restructuring                
Restructuring activity expense         200,000      
Oakville, Ontario, Canada | Facility Closing                
Restructuring                
Restructuring activity expense         700,000      
Oakville, Ontario, Canada | Other Restructuring                
Restructuring                
Restructuring activity expense         $ 200,000